Gufic Biosciences Limited (NSE:GUFICBIO)
India · Delayed Price · Currency is INR 355.25
-2.40 (-0.67%)
Jun 19, 2026, 3:29 PM IST
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 35.7 billion as of June 18, 2026. Its market cap has decreased by -8.91% in one year.
Market Cap
35.70B
Enterprise Value
38.99B
Revenue
9.44B
Ranking
n/a
PE Ratio
55.60
Stock Price
355.25
Market Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 35.70B, an increase of 9,896.36%. That is a compound annual growth rate of 19.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 35.70B | 5.72% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akums Drugs and Pharmaceuticals | 92.12B |
| Sun Pharma Advanced Research Company | 77.76B |
| Aarti Pharmalabs | 58.76B |
| Innova Captab | 53.50B |
| Orchid Pharma | 51.14B |
| RPG Life Sciences | 38.07B |
| Solara Active Pharma Sciences | 28.01B |
| Indoco Remedies | 21.34B |